For people without insurance coverage, compounded semaglutide is often a financially accessible option
there are a lot of really good benefits to [other conditions] that that could be expensive, that are more expensive than the drug, especially with the drug cost coming down. SVP Human Resources, large non-profit One in three (34%) firms require lifestyle or clinical support programs before allowing employees to receive GLP-1 agonists for weight loss About a third (34%) of firms covering GLP-1 agonists for weight loss require enrollees to meet with a dietitian, case manager, therapist, or participate in a lifestyle program in order to have the medications covered, up from 10% of firms last year
doi: 10.15420/cfr 45 XieYBoweBGibsonAKMcGillJBMaddukuriGYanYet al
Eligible comparators included placebo or active treatments such as standard care, sodiumglucose cotransporter 2 (SGLT2) inhibitors, finerenone, reninangiotensinaldosterone system (RAAS) inhibitors, or other glucose-lowering agents
2002;23 Suppl 3:11-144